Login to Your Account

Aslan kicks off IPO on Taipei Exchange with public auction

By Chris Horton
Staff Writer

Thursday, May 11, 2017

TAIPEI, Taiwan – Aslan Pharmaceuticals Pte. Ltd., a Singapore-based company focused on the development of treatments for prevalent tumor types in Asia, is conducting a competitive auction and public offer of common shares for its initial listing on the TPEx.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription